50 search results for:
Large Stock Spikes for Some Covid-19 Vaccine Makers
January 12, 2021 /in Analysts, AstraZeneca, BioNTech, Biopharma, Biotech, BNT162b2 (Pfizer and BioNTech), Business, Clinical Trials, CNBC, COVID-19 Vaccines, Emergency Use Authorization, FDA, Johnson & Johnson, Novavax, Pfizer, R&D, Stocks, Trading
Publicly traded companies that have been heavily involved in developing therapies and vaccines for Covid-19 have experienced significant spikes in their stock prices from March 2020 to January 2021, including Germany's BioNTech, which surged 187% in one year.
'No limit' – the more exercise the better, heart health study finds
January 12, 2021 /in Cardiovascular Disease, Cardiovascular Health, Exercise, Heart Disease, Heart Health, Oxford University, Researchers, Scientists, Studies
When it comes to matters of heart health, no amount of exercise is too much, scientists said regarding research that debunks the myth that high levels of vigorous physical activity might not always be beneficial.
SubjectWell releases data on liver disease patients
January 12, 2021 /in Business, Ethnicity, Fatty liver disease (NASH), Hispanics, Liver Disease, Non-alcoholic steatohepatitis (NASH), Patients, Survey Data, Surveys
SubjectWell – the largest risk-free clinical trials marketplace – released statistics on patients' attitudes toward clinical research, specifically those with liver diseases.
Herd Immunity to Covid-19 Likely Will Not Be Achieved in 2021, Experts Suggest
January 12, 2021 /in 'Herd Immunity'
The advancing rollout of approved Covid-19 vaccines provides hope to many that existing lockdowns and social restrictions will soon be lifted, but experts suggest a "return to normal" likely will not occur until herd immunity is achieved.
Gilead Updates 2020 Guidance with Post-Holiday Covid-19 Spike
January 12, 2021 /in Gilead, Remdesivir
Despite some controversy over the effectiveness of Gilead Sciences' Veklury (remdesivir) as the first antiviral drug approved to treat Covid-19, the product is bolstering the company's bottom line and 2020 guidance was updated to reflect that.
Webinar: Strategies to Accelerate Gene Therapy Process Development from Preclinical to Manufacturing
January 12, 2021 /in Business, Gene Therapy, Manufacturing, Webinars
Gene therapy is a fast-growing industry. Though demand for its products – including pDNA, AAV, retrovirus, lentivirus and others – has significantly increased over the last 10 years, production challenges have remained unresolved.
Enalare Therapeutics Completes Formation of Scientific Advisory Board
January 12, 2021 /in Advisory Boards, Appointments, Biopharma, Business, People on the Move, Respiratory Conditions
Enalare Therapeutics Inc., dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced the completed formation of the clinical stage biopharmaceutical company's scientific advisory board.
U.S. to release Covid-19 doses in push for older Americans to get shots
January 12, 2021 /in Department of Health and Human Services (HHS), U.S. Health Secretary Alex Azar
The Trump administration plans to release Covid-19 vaccine doses it had been holding back for second shots and will urge states to offer them to all Americans over age 65, according to U.S. Department of Health and Human Services Secretary Alex Azar.
Sanofi and Biond Biologics to collaborate on new cancer drug
January 12, 2021 /in Sanofi
Biond Biologics Ltd. forged an exclusive global license agreement, potentially worth more than $1 billion, with French drugmaker Sanofi for the development and commercialization of the Israeli company's BND-22 cancer drug.
GSK, Vir to test antibody for Covid-19 treatment
January 12, 2021 /in GlaxoSmithKline
British drugmaker GSK and U.S.-based Vir Biotechnology will evaluate a second antibody-based treatment in patients with mild to moderate Covid-19 in an early-stage to mid-stage trial.